Private equity firm Cerberus infuses $105M into vaccine maker PaxVax
PaxVax will use the funding to pay off its debts, as well as launch a cholera vaccien called Vaxchora.
PaxVax will use the funding to pay off its debts, as well as launch a cholera vaccien called Vaxchora.